Can a simple questionnaire predict who will follow their treatment?

NCT ID NCT06856902

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a tool called B-COMPASS that uses a 22-question survey to predict whether people will follow their prescribed treatments. Researchers will enroll 3100 adults with cardiovascular, endocrine, immune, nerve, cancer, or rare diseases across Europe. The goal is to see if the tool can accurately identify who needs extra support to improve adherence and health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AHUS - Akershus University Hospital

    RECRUITING

    Lørenskog, Akershus, 1478, Norway

  • APDP Diabetes Portugal

    RECRUITING

    Lisbon, 1250-203, Portugal

  • FHUNJ - Fundación para la Investigación Biomédica del Hospital Infantil Universitario Niño Jesús

    RECRUITING

    Madrid, Spain

  • FIIBAP - Fundación para la Investigación e Innovación Biosanitaria de Atención Primaria

    RECRUITING

    Madrid, Spain

  • FISM - Italian Multiple Sclerosis Foundation

    RECRUITING

    Genova, Italy

  • KCRI - Kilimanjaro Clinical Research Institute

    NOT_YET_RECRUITING

    Moshi, Tanzania

  • MEDCIDS - Departamento de Medicina da Comunidade Informação e Decisão em Saúde

    RECRUITING

    Porto, Portugal

  • UDUS - Heinrich-Heine-University Duesseldorf

    RECRUITING

    Düsseldorf, Germany

  • UMCM - University Medical Center Maribor

    RECRUITING

    Maribor, Slovenia

  • WDO - World Duchenne Organization

    RECRUITING

    Veenendaal, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.